Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Vilaprisan - Bayer HealthCare Pharmaceuticals

Drug Profile

Vilaprisan - Bayer HealthCare Pharmaceuticals

Alternative Names: BAY 1002670; Bayer-sPRM; S-PRAnt; S-PRM; sPRM

Latest Information Update: 11 Apr 2020

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bayer Schering Pharma
  • Developer Bayer HealthCare Pharmaceuticals
  • Class Antineoplastics; Antiprogestogens; Infertility therapies; Small molecules; Sulfones
  • Mechanism of Action Progesterone receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Uterine leiomyoma
  • Phase II Endometriosis

Most Recent Events

  • 06 Feb 2019 Bayer completes a phase I trial in Endometriosis and Uterine leiomyoma (In adults, In the elderly) in USA (PO) (NCT03411980)
  • 23 Jan 2019 Bayer completes a phase I drug-drug interaction trial in Healthy volunteers in Germany (PO) (NCT03210246)
  • 08 Oct 2018 Bayer plans the ASTEROID 7 phase III trial for Uterine leiomyoma in Japan, Russia, South Africa, Turkey (PO) in October 2018 (NCT03699176)
Restricted Access

If your organization has a subscription then there are several options available to help you access AdisInsight while working remotely. Contact us at AsktheExpert.AdisInsight@springer.com to find out more.
Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top